Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_assertion type Assertion NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_head.
- NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_assertion description "[Moreover, S1P analog therapy allows for sufficient anti-influenza T cell and antibody formation to control infection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_provenance.
- NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_assertion evidence source_evidence_literature NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_provenance.
- NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_assertion SIO_000772 21901448 NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_provenance.
- NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_assertion wasDerivedFrom befree-20140225 NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_provenance.
- NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_assertion wasGeneratedBy ECO_0000203 NP329723.RA_QLVv-rqgCroa-mt69bzcrDjsfRZtgnaOUWrY9f7vRY130_provenance.